Research Article DETERMINATION OF LOMEFLOXACIN IN PHARMACEUTICALS USING DIFFERENTIAL PULSE POLAROGRAPHIC ANALYSIS 1 ABDUL AZIZ RAMADAN * , 2 HASNA MANDIL Dept. of Chemistry, Faculty of Sciences, Aleppo University, Syria. 1 Email: [email protected]Received: 17 July 2012, Revised and Accepted: 29 Aug 2012 ABSTRACT The electrochemical behavior of Lomefloxacin (LFLX) at dropping mercury electrode (DME) in 0.05M Na2HPO4 over the pH range 4.0–11 has been studied using differential pulse polarographic analysis (DPPA). At 4.0≤pH≤8.5 one reduction peak was observed in the potential range of –1.260 to - 1.350V and at 8.7≤ pH≤10.0 two peaks were observed; the first was in the range of -1.376 to -1.500V while the second was in the range of -1.590 to - 1.594 V. Finally at pH >10.0, only one peak was observed in the range of -1.760 to -1.767V. A simple, precise, inexpensive and sensitive DPPA has been developed for the determination of LFLX. A linear calibration was obtained in the range of 1.0–100 µmol.L -1 at pH 7.0 and in the range of 4.0– 200 µmol.L -1 at pH 9.25. RSD was less than 3.6% (n=5) at all concentration levels. The method was successfully applied for the determination of LFLX in pharmaceuticals. Keywords: Lomefloxacin, Pharmaceuticals, Differential Pulse Polarographic Analysis. INTRODUCTION Lomefloxacin (LFLX),[1-ethyl-6,8-difluoro-1,4- dihydro-7-(3-methyl- 1-piperazinyl)-4-oxo-3-quinolinecarboxylix acid], with formula C17H19F2N3O3, (mw:351.348 g/mol), (or, the maternal is also available commercial us hydrochloride formed of Lomefloxacin hydrochloride C17H19F2N3O3.HCl) experimental, (Scheme1), is one of the synthetic antibacterial fluoroquinolone agents of the third generation, which exhibits high activity against a broad spectrum of Gram-negative and Gram-positive bacteria. This material is broadly medicated for treatment of the urinary tract and respiratory infections 1,2 . Various analytical techniques have been utilized for the determination of Fluorquinolone such as high-performance liquid chromatography (HPLC) 3–8 ,liquid chromatography–tandem mass spectrometry 10 , analytical high performance thin layer chromatography(HPTLC) 11 , spectrophotometry 12-18 , fluorometry 19-22 and electrochemical methods 23-37 . The polarographic analysis was successfully applied for determination some drugs as Gatifloxacin 34 , Carbinoxamine Maleate 35 , Dipyrone 36 and Atorvastatin 37 . In the present study, differential pulse polarographic behaviour and determination of Lomefloxacin in phosphate buffer using dropping mercury electrode (DME) was applied. Scheme 1: Chemical structure of Lomefloxacin(A), Lomefloxacin Hydrochloride(B) MATERIALS AND METHODS Reagents Sodium tetraborate decahydrate (Na2B4O7·10H2O), disodium hydrogenphosphate (Na2HPO412H2O), sodium hydroxide (NaOH) and phosphoric acids, were purchased from Merck. Lomefloxacin was obtained from National Institute for The Control of Pharmaceutical and Biological Products (Beijing, China). Stock standard 0.001 mol.L −1 of Lomefloxacin hydrochloride (purity >99.5%) was prepared by dissolving 38.78 mg standards in double distilled water. This solution was found to be stable for three weeks, that if stored at −4 ◦ C in dark flask. Standard working solutions were prepared by diluting the standard stock solution just before use. Working standards were prepared daily by diluting different volumes of stock solution (0.025, 0.050, 0.10, 0.20, 0.30, 0.40, 0.60, 0.80, 1.00, 2.00, 3.00, 4.00 and 5.00 mL) with 12.5 mL supporting electrolyte of disodium hydrogen phosphate or sodium tetraborate decahydrate, adjusting the pH as required using in the appropriate volume of phosphoric acid 0.10 mol.L −1 or sodium hydroxide 0.2 mol.L −1 and then diluting to 25 mL with double-distilled water. Supporting electrolyte of 0.10 mol.L −1 was prepared by dissolving 35.814g of Na2HPO4.12H2O or 38.1g of Na2B4O7·10H2O in 1000 mL volumetric flask using double-distilled water. All solutions and reagents were prepared with double- distilled deionised water and analytical grade chemicals. Ultrapure mercury from Metrohm Company was used throughout the experiments. Instruments and apparatus A Metrohm 797 VA processor. A Metrohm 797 VA stand with a multi-mode electrode (MME) comprising a dropping mercury electrode (DME) as a working electrode, an auxiliary platinum electrode and a reference electrode (Ag/AgCl) saturated with a 3.0 mol.L −1 KCl solution and the three-electrode cell were used. pH– meter (Radiometer company model Ion Check) was used. All measurements were done at room temperature 25±2°C. Highly pure nitrogen gas (99.999%) was used for de-oxygenation. Analytical procedure 25 mL of working standard of Lomefloxacin was transferred to the cell. The solution was well mixed by automatic mixer and deoxygenated with nitrogen gas for 5 min. Current-voltage curves were recorded. Limiting currents were measured and calibration curves in electrolytes were constructed. Sample preparation Commercial formulations Lomeflox and Quino: Ctd. tab and Lomoquin: drop, Dalta-flox- Aleppo- Syria, which contain 400 mg/tab. and 0.3% of Lomefloxacin (or 441 mg/tab. and 0.33% Lomefloxacin.HCl), were used for the analysis of LFLX by the DPP method. Eight tablets of pharmaceutical formulations Lemoflox and Quino were weighed and ground to a fine powder. A quantity equivalent to one tablet was weighed, dissolved in water, transferred to a 100 mL volumetric flask and diluted to the mark with water. An accurately volume 0.100 mL sample solution of tablet or drop was added to 12.5 mL of supporting electrolyte disodium hydrogen phosphate, adjust to the desired pH (7.0 or 9.25) using phosphoric acid 0.10 mol.L −1 or sodium hydroxide solution 0.20 mol.L −1 , then transferred into a 25 mL standard flask and diluted to the mark with double-distilled water. International Journal of Pharmacy and Pharmaceutical Sciences ISSN- 0975-1491 Vol 4, Suppl 5, 2012 A A c c a a d d e e m mi i c c S Sc c i i e e n n c c e e s s
7
Embed
determination of lomefloxacin in pharmaceuticals using differential ...
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Research Article
DETERMINATION OF LOMEFLOXACIN IN PHARMACEUTICALS USING DIFFERENTIAL PULSE
POLAROGRAPHIC ANALYSIS
1ABDUL AZIZ RAMADAN*, 2HASNA MANDIL
Dept. of Chemistry, Faculty of Sciences, Aleppo University, Syria. 1Email: [email protected]
Received: 17 July 2012, Revised and Accepted: 29 Aug 2012
ABSTRACT
The electrochemical behavior of Lomefloxacin (LFLX) at dropping mercury electrode (DME) in 0.05M Na2HPO4 over the pH range 4.0–11 has been
studied using differential pulse polarographic analysis (DPPA). At 4.0≤pH≤8.5 one reduction peak was observed in the potential range of –1.260 to -
1.350V and at 8.7≤ pH≤10.0 two peaks were observed; the first was in the range of -1.376 to -1.500V while the second was in the range of -1.590 to -
1.594 V. Finally at pH >10.0, only one peak was observed in the range of -1.760 to -1.767V. A simple, precise, inexpensive and sensitive DPPA has
been developed for the determination of LFLX. A linear calibration was obtained in the range of 1.0–100 µmol.L-1 at pH 7.0 and in the range of 4.0–
200 µmol.L-1 at pH 9.25. RSD was less than 3.6% (n=5) at all concentration levels. The method was successfully applied for the determination of
The influence of the phosphate buffer solution (pH 4.0 – 11.0) on the peak current (Ip) and peak potential (Ep) were examined. The polarograms of the differential pulse polarographic (DPP) analysis for 40 µmol.L−1 and 80 µmol.L−1 Lomefloxicin hydrochloride in phosphate buffer (in the presence of 0.05 mol.L−1 Na2HPO4) at different pH values using dropping mercury electrode (DME) shown in Fig.1. At pH values between 4.0–8.5, only one reduction peak in the range of potential at –1.260 to -1.350V (Ep1) was observed. Increase the pH within the range shift the Ep1 value to the negative direction, Fig.2(A), with almost constant Ip1 value to pH 7, then decreases sharply, Fig.2(B). At pH values between 8.7–10.0, two reduction peaks were observed, the first peak (Ep1) is in the range of potential at -1.380 to -1.500 V, while the second peak (Ep2) is in the potential ranges at -1.590 to -1.594 V, Fig.2(A). In this pH range the Ip1 > Ip2 and the value of Ip1 decrease. Ip2 increase until pH 9.25 and then decrease after that, Fig.2(B). Finally at pH >10.0, only one peak in the range of potential (Ep2) at -1.758 to -1.770 V was observed, Fig.2(A), and Ip2 sharply increase, Fig.2(B). The shift of E, with pH indicates that the electron uptake is preceded by a proton transfer as proposed earlier for Nalidixic acid, Gatifloxacin and others23, 29-33.
Proposed mechanism for Lomefloxacin reduction at the DME
By comparison with norfloxacin and Gatifloxacin [24, 29-31],
Lomefloxacin (HAN), it is expected to exist in aqueous media with
intermediate pH values (3.0-8.5) as a zwitterion, HAZ, a neutral molecule,
HAN; where, it shows the first peak in accordance to the equation:
HAZ + e → HAZ- (I)
It is expected that, zwitterions, HAZ will be the major existing species
since one of the nitrogen atoms in the piperazine moiety is more
basic than the carboxylate ion, according to the equation (I) (only
first peak appears). In a weak basic medium (8.5≤ pH ≤ 10.0) the
conjugate base HAZ, HAN and A- ; where reduces HAZ according to the
equation (I), first peak, and A-, second peak, accordance to the
following equations:
However, in a strong basic medium (pH > 10) the conjugate base A-
predominates according to the following equation:
In this case only second peak appears according to equation (III). Based on the deferential pulse polarograms in base electrolytes of
wide pH ranges, the appearance or disappearance of peaks
according to pH values of solutions, the above-mentioned proposed
equilibrium, we suggest the reduction of Lomefloxacin at the DME
may take place according to the equations of Scheme 2.
Fig. 1: The effect of pH values on DPP analysis of Lomefloxacin 80µM using DME in phosphate buffer ; polarograms (1 - 14) represent pH
Fig. 2: The effect of pH values on Ep1, Ep2(A) and Ip1, Ip2(B) of Lomefloxacin 80µM using DME in phosphate buffer .
Ramadan et al.
Int J Pharm Pharm Sci, Vol 4, Suppl 5, 255-261
257
Scheme 2: Electrochemical reduction of Lomefloxacin at DME
Effect of pulse amplitude
The effect of pulse amplitude on polarograms of DPP using DME for
the determination of Lomefloxacin in phosphate buffer (pH 7.0 &
9.25) was studied. The peak current Ip increases proportionally with
increasing of pulse amplitude negative polarity (DPPNP) and pulse
amplitude positive polarity (DPPPP) up to the value 100 mV.
Therefore the value of pulse amplitude 90 mV for DPPNP was
chosen as optimum value, see Fig.3.
Effect of electrolyte
The effect of electrolytes (Na2B4O7·10H2O and Na2HPO4.12H2O ) in
the peak current of LFLX was studied . It was found that, the most
suitable electrolyte is Na2HPO4.12H2O . Since the usage of
Na2HPO4.12H2O (0.05M) as an electrolyte gave a higher and sharper
peak than Na2B4O7·10H2O, see Fig.4.
Calibration curves
Calibration curves for the determination of Lomefloxacin by DPP using DME electrodes at pH=7.0 were studied. Only one peak was observed, the peak current (Ip) was proportional to the concentration of Lomefloxacin over the ranges 1.0 – 100 μmol.L−1 (y=-7.464X-13.35, R2=0.9998; y: Ip, nA and X: CLFLX, μmol.L−1). At pH = 9.25, the peak current (Ip1) was proportional to the concentration of Lomefloxacin over the ranges 4.0 – 200 μmol.L−1 (y=-3.390X+12.65, R2=0.9995) and the peak current (Ip2) was proportional to the concentration of Lomefloxacin over the ranges 4.0 – 200 μmol.L−1 (y=-1.621X-7.581, R2=0.9999),see Fig.5 and Tables 1-3. The limit of quantifying LFLX was 1.0 μmol.L−1 for Ip1 at pH 7 and 4.0 μmol.L−1 for Ip1 and Ip2 at pH
9.25 with the relative standard deviation (RSD) of ± 3.6 %,
± 3.8 % and ± 4.2 % respectively.
Ramadan et al.
Int J Pharm Pharm Sci, Vol 4, Suppl 5, 255-261
258
Fig. 3: The effect of pulse amplitude on DPP analysis of Lomefloxacin 80µM using DME: A) Ip1 at pH 7.0, B) Ip1(1) & Ip2(2) at pH 9.25 ; C)
Ip1 at pH 7.0, D) Ip1(1) & Ip2(2) at pH 9.25 (A & B negative pulse and C & D positive pulse).
Fig. 4: The effect of concentration of electrolyte on Ip of Lomefloxacin 80µM using DME:A) Ip1 at pH 7.0; B) Ip1&Ip2 at pH 9.25
Fig. 5: Calibration curves for the determination of Lomefloxacin by DPP with DME: A) at pH 7.0; B) at pH 9.25 (1-Ip1, 2-Ip2).
Ramadan et al.
Int J Pharm Pharm Sci, Vol 4, Suppl 5, 255-261
259
Table 1: Evaluation of accuracy and precision of the proposed methods for determination of lomefloxacin using DME by DPPNP at pH 7
CLFLX taken., ∝∝∝∝M CLFLX. found,
X , µM
SD, µM
Analytical standard error, n
SD
, µM
Confidence limits
X ± n
SD
t, µM
RSD %
1.00 1.00 0.036 0.016 1.00 ± 0.045
3.6
2.00 1.99 0.068 0.030 1.99 ± 0.084
3.4
4.00 4.05 0.122 0.054 4.05 ± 0.151
3.0
8.00 8.00 0.224 0.100 8.00 ± 0.278
2.8
10.00 9.98 0.269 0.121 9.98 ± 0.335
2.7
12.00 11.98 0.288 0.129 11.98 ± 0.370
2.4
20.00 20.15 0.403 0.180 20.15 ± 0.500
2.0
30.00 30.00 0.510 0.228 30.00 ± 0.633
1.7
40.00 39.96 0.599 0.268 39.96 ± 0.744
1.5
80.00 79.98 0.960 0.429 79.98 ± 1.191
1.2
100.0 100.0 1.00 0.447 100.0 ± 1.242
1.0
Table 2: Evaluation of accuracy and precision of the proposed methods for determination of lomefloxacin using DME by DPPNP (Ep1) at pH
9.25
CLFLX taken., µM CLFLX. found,
X , µM
SD, µM
Analytical standard error, n
SD
, µM
Confidence limits
X ± n
SD
t, µM
RSD %
4.00 4.08 0.155 0.069 4.08 ± 0.192
3.8
8.00 8.12 0.284 0.127 8.12 ± 0.353
3.5
10.00 10.04 0.321 0.144 10.04 ± 0.399
3.2
12.00 12.00 0.360 0.161 12.00 ± 0.447
3.0
20.00 19.93 0.558 0.250 19.93 ± 0.693
2.8
40.00 40.21 1.045 0.468 40.21 ± 1.298
2.6
80.00 80.06 1.841 0.824 80.06 ± 2.286
2.3
120.0 120.5 2.53 1.13 120.5 ± 3.14
2.1
160.0 161.4 2.91 1.30 161.4 ± 3.61
1.8
200.0 201.6 3.23 1.44 201.6 ± 4.00
1.6
Table 3: Evaluation of accuracy and precision of the proposed methods for determination of lomefloxacin using DME by DPPNP (Ep2). at
pH 9.25
CLFLX taken., µM CLFLX. found,
X , µM
SD, µM
Analytical standard error, n
SD
, µM
Confidence limits
X ± n
SD
t, µM
RSD %
4.00 4.10 0.172 0.077 4.10 ± 0.214
4.2
8.00 7.97 0.287 0.128 7.97 ± 0.356
3.6
10.00 10.00 0.320 0.143 10.00 ± 0.379
3.2
12.00 11.92 0.358 0.160 11.92 ± 0.444
3.0
20.00 20.40 0.571 0.255 20.40 ± 0.709
2.8
40.00 40.21 1.045 0.468 40.21 ± 1.298
2.6
80.00 80.92 2.023 0.905 80.92 ± 2.512
2.5
120.0 119.8 2.64 1.18 119.8 ± 3.27
2.2
160.0 159.6 3.19 1.43 159.6 ± 3.96
2.0
200.0 201.0 3.62 1.62 201.0 ± 4.49
1.8
Ramadan et al.
Int J Pharm Pharm Sci, Vol 4, Suppl 5, 255-261
260
Table 4: Determination of lomefloxacin in some pharmaceutical formulations using DPPNP methods on DME at pH= 7.0
Commercial
name
Contents,mg
x , mg
RSD% Recovery %
Lomeflox,Ctd.tab.
Balsam.Pharma Co.
(Homs- -Syria)
400mg/tab. 408 2.2 102.0
Quino, Ctd.tab.
Alfares pharmaceuticals Co.
Damascus – Syria
400mg/tab. 404 2.4 101.0
Dalta-flox,Drop
Delta for medicaments
Aleppo – Syria
0.30% 0.31% 2.8 103.3
Lomoquin, Drop
Medico Labs.
(Homs- -Syria)
0.30% 0.32% 2.6 106.6
Table 5: Determination of lomefloxacin in some pharmaceutical formulations using DPPNP methods on DME at pH= 9.25
Commercial
name
Contents,mg
x , mg
RSD% Recovery %
Lomeflox,Ctd.tab.
Balsam.Pharma Co.
(Homs- -Syria)
400mg/tab. 410 2.4 102.5
Quino, Ctd.tab.
Alfares pharmaceuticals Co.
Damascus – Syria
400mg/tab. 406 2.4 101.5
Dalta-flox,Drop
Delta for medicaments
Aleppo – Syria
0.30% 0.30% 3.0 100.0
Lomoquin, Drop
Medico Labs.
(Homs- -Syria)
0.30% 0.32% 2.9 106.6
APPLICATIONS
Many applications for the determination of Lomefloxacin in
pharmaceutical preparations: Lomeflox and Quino :Ctd. tab and
Lomoquin : drop, Dalta-flox- Aleppo- Syria, which contain 400
mg/tab. and 0.3% of Lomefloxacin (or 441 mg/tab. and 0.33%
Lomefloxacin.HCl) using differential pulse polarography in
phosphate buffer at pH 7 and 9.25 on DME were proposed. The
above obtained sample solutions were applied to the differential
pulse polarography determination of Lomefloxacin. The results of
quantitative analysis for Lomfloxacin were calculated by calibration
curves and the standard addition methods, see Tables 4&5.
CONCLUSION
In the proposed method, differential pulse polarographic analysis of
Lomefloxacin in both pure form and pharmaceutical formulations at
pH 7.0 and pH 9.25 over the range of 1.0 – 100 μmol.L−1 at pH 7.0
and in the range of 4.0 – 200 μmol.L−1 at pH 9.25 using DME was
applied. Applying over mentioned methods in this context was
successfully carried out for the first time. The relative standard
deviation (RSD) did not exceed of ± 3.6%, ± 3.8% and ± 4.2 % at
pH 7.0 for Ip1 and pH 9.25 for Ip1and Ip2 respectively. The method
was successfully applied for the determination of LFLX in
pharmaceuticals.
REFERENCES
1. Wang Xu, Zhao Huichun, Nie Lihua, Jin Linpei, Zhang Zhonglun,
Europium sensitized chemiluminescense determination of
rufloxacin. Anal Chimi Acta, 2001; 445: 169–175.
2. Zhanel GG, Noreddin AM., Pharmacokinetics and
pharmacodynamics of the new fluoroquinolones: focus on